Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 28;17(3):753-758.
doi: 10.1016/j.radcr.2021.12.029. eCollection 2022 Mar.

Biotin-thiamine-responsive basal ganglia disease: A case report

Affiliations
Case Reports

Biotin-thiamine-responsive basal ganglia disease: A case report

Shamaita Majumdar et al. Radiol Case Rep. .

Erratum in

Abstract

Biotin-Thiamine-Responsive Basal Ganglia Disease is an extremely rare autosomal recessive neurometabolic disorder characterized by recurrent waxing and waning episodes of subacute encephalopathy and seizures. High dose biotin and thiamine administration has been shown to improve symptoms within days, and the symptoms may reappear rapidly if supplementation is discontinued. Here we present a case of a 20-year-old male with classical clinical and imaging findings of Biotin-Thiamine-Responsive Basal Ganglia Disease, with a 12-year delay in diagnosis, finally diagnosed after presenting at our institution based on imaging and subsequent reexamination of exome sequencing. In this report, we review the classic imaging findings in this disease and examine why making the diagnosis can be extremely challenging due to its wide differential. Both clinically and radiographically, this condition demonstrates significant overlap with a vast array of disease entities, ranging from viral or autoimmune encephalitis to metabolic disorders. Finally, we discuss the various negative prognostic predictors described in the literature, several of which were observed in this patient's clinical course.

Keywords: Basal ganglia; Biotin-thiamine-responsive basal ganglia disease; Neurometabolic disorder; Seizure disorder; Thiamine transporter-2 gene.

PubMed Disclaimer

Figures

Fig. 1 –
Fig. 1
Axial magnetic resonance images of the brain during acute encephalopathic phase. (A) FLAIR sequence images demonstrate symmetric signal hyperintensity of the caudate, putamen, and medial thalami bilaterally, along with asymmetric scattered cortical hyperintensities. (B) FLAIR sequence at level of midbrain demonstrates increased signal of the periaqueductal gray matter. (C) Diffusion-weighted images show symmetric restricted diffusion in the bilateral basal ganglia corresponding to areas of increased FLAIR signal. (D) Post-contrast images demonstrate heterogenous enhancement of bilateral caudate and putamen.
Fig. 2 –
Fig. 2
Axial magnetic resonance images of the brain near end of hospital course. (A) Compared to Figure 1A, there is decreased FLAIR hyperintensity involving bilateral ganglia. (B) Diffusion-weight images demonstrates mild residual restricted diffusion in the bilateral basal ganglia, decreased compared to prior exam.

References

    1. Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83. doi: 10.1186/1750-1172-8-83. Epub 2013/06/08PubMed PMID: 23742248PubMed Central PMCIDPMCPMC3691666. - DOI - PMC - PubMed
    1. Kassem H, Wafaie A, Alsuhibani S, Farid T. Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment. Am J Neuroradiol. 2014;35(10):1990–1995. - PMC - PubMed
    1. Zeng W-Q, Al-Yamani E, Acierno JS, Slaugenhaupt S, Gillis T, MacDonald ME, et al. Biotin-responsive basal ganglia disease maps to 2q36. 3 and is due to mutations in SLC19A3. Am J Hum Genet. 2005;77(1):16–26. - PMC - PubMed
    1. Algahtani H, Ghamdi S, Shirah B, Alharbi B, Algahtani R, Bazaid A. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment. Neurol Res. 2017;39(2):117–125. doi: 10.1080/01616412.2016.1263176. Epub 2016/12/03PubMed PMID: 27905264. - DOI - PubMed
    1. Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, et al. Biotin-responsive basal ganglia disease: a novel entity. Brain. 1998;121(7):1267–1279. - PubMed

Publication types